Two temperature-dependent membrane fluidity regimes in Gram-positive bacteria
Barbotin A +3 more
europepmc +1 more source
A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibiotics. [PDF]
Zhang Q +11 more
europepmc +1 more source
Clinical implementation of endolysins targeting gram-positive bacteria points toward a combination strategy with standard-of-care antibiotics: a selective review. [PDF]
Vander Elst N.
europepmc +1 more source
Clinical impact and disparities in mortality and antimicrobial resistance between Gram-negative and Gram-positive bacteria in cirrhotic abdominal infections: a meta-analysis. [PDF]
Xie XQ, Shao JW.
europepmc +1 more source
Interactions of <i>Galleria mellonella</i> Proline-Rich Antimicrobial Peptides with Gram-Negative and Gram-Positive Bacteria. [PDF]
Zdybicka-Barabas A +8 more
europepmc +1 more source
The avermectin, emamectin benzoate, kills gram-positive bacteria and targets the cell envelope of <i>Bacillus subtilis</i>. [PDF]
Ahmad R +5 more
europepmc +1 more source
Selenocompounds as Potent Efflux Pump Inhibitors on Gram-positive Bacteria. [PDF]
Kincses A +6 more
europepmc +1 more source
MecA: A Multifunctional ClpP-Dependent and Independent Regulator in Gram-Positive Bacteria. [PDF]
Wen ZT, Ellepola K, Wu H.
europepmc +1 more source
Presence of viable gram-positive bacteria in blood of patients with inflammatory bowel disease is not affected by treatment. [PDF]
Davidson S +4 more
europepmc +1 more source
Design, synthesis, and biological evaluation of derivatives from p-toluic hydrazide: lead compound C17 exhibits membrane-disrupting and anti-biofilm activities against <i>Staphylococcus aureus</i> and other gram-positive bacteria. [PDF]
Liu Y, Hu L, Liu B, Qu Z.
europepmc +1 more source

